Cropsey Karen L, Willig James H, Mugavero Michael J, Crane Heidi M, McCullumsmith Cheryl, Lawrence Sarah, Raper James L, Mathews W Christopher, Boswell Stephen, Kitahata Mari M, Schumacher Joseph E, Saag Michael S
University of Alabama at Birmingham (KLC, JHW, MJM, CMcC, SL, JLR, JES, MSS), Birmingham, AL; University of Washington (HMC, MMK), Seattle, WA; University of California, San Diego (WCM), San Diego, CA; Fenway Community Health Center (SB), Boston, MA.
J Addict Med. 2016 Jan-Feb;10(1):13-9. doi: 10.1097/ADM.0000000000000172.
The prevalence of smoking among HIV-infected individuals is 2-3 times that of the general population, increasing the risk of smoking-related morbidity and mortality. We examined characteristics associated with smoking behavior among a large cohort of HIV-infected individuals in care in the United States.
A convenience sample of 2952 HIV-infected patients in the Centers for AIDS Research (CFAR) Network of Integrated Clinical Systems (CNICS) was assessed during routine clinic visits and was included. Multinomial logistic regression was used to examine the relationship between smoking status, depression/panic symptoms, alcohol/substance use, and demographic and clinical characteristics.
Compared with never-smokers, current smokers were more likely to have moderate to severe depression (odds ratio [OR] 1.37), endorse current substance use (OR 14.09), and less likely to report low-risk alcohol use on the Alcohol Use Disorders Identification Test (AUDIT-C) (OR 0.73). Current smokers were less likely to have an undetectable viral load (OR 0.75), and more likely to have current substance abuse (OR 2.81) and moderate to severe depression (OR 1.50), relative to smokers who had quit smoking.
HIV-infected smokers are less likely to have undetectable viral loads and frequently have psychosocial comorbidities including depression and substance abuse that impact antiretroviral therapy adherence and viral load suppression. To be effective, smoking-cessation interventions need to address the complex underlying concurrent risks in this population.
HIV感染者中的吸烟率是普通人群的2至3倍,这增加了与吸烟相关的发病和死亡风险。我们在美国接受治疗的一大群HIV感染者中研究了与吸烟行为相关的特征。
在常规门诊就诊期间,对艾滋病研究中心(CFAR)综合临床系统网络(CNICS)中的2952名HIV感染患者进行了便利抽样评估,并将其纳入研究。采用多项逻辑回归分析来研究吸烟状况、抑郁/惊恐症状、酒精/物质使用与人口统计学和临床特征之间的关系。
与从不吸烟者相比,当前吸烟者更有可能患有中度至重度抑郁症(优势比[OR]为1.37),认可当前使用物质(OR为14.09),并且在酒精使用障碍识别测试(AUDIT-C)中报告低风险饮酒的可能性较小(OR为0.73)。与已戒烟的吸烟者相比,当前吸烟者病毒载量不可检测的可能性较小(OR为0.75),当前存在物质滥用(OR为2.81)和中度至重度抑郁症(OR为1.50)的可能性更大。
感染HIV的吸烟者病毒载量不可检测的可能性较小,并且经常伴有包括抑郁症和物质滥用在内的心理社会合并症,这些合并症会影响抗逆转录病毒治疗的依从性和病毒载量抑制。为了取得成效,戒烟干预措施需要解决该人群中复杂的潜在并发风险。